Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
New Regulations Proposed for Clinical Trials in Europe to Enhance Transparency
Proposed regulations aim to enhance transparency and data sharing in European clinical trials....
European Biopharma Companies Collaborate on mRNA Vaccine Development
Several European biopharma companies have announced a new collaboration aimed at advancing mRNA vaccine technology....
New Advanced Manufacturing Techniques Transform Biopharma Production Efficiency in Europe
New manufacturing technologies are set to enhance production efficiency in Europe's biopharma industry....
European Biopharma Leaders Forge New Collaborative Initiative for Innovative Drug Development
European biopharma leaders announced a new initiative aimed at accelerating innovative drug development through enhanced collaboration....
FDA Grants Breakthrough Therapy Designation to Izalontamab Brengitecan for Lung Cancer
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to izalontamab brengitecan (Iza-bren), an investigational treatment for adults with advanced non-small cell lung cancer (NSCLC). ...
Porosome Therapeutics Announces Breakthrough Discoveries in Alzheimer’s Research
Porosome Therapeutics, Inc. had announced major progress in the fight against Alzheimer’s Disease (AD) with a first-of-its-kind therapeutic platform that addresses the root causes of the condition, rather than just managing symptoms....
AstraZeneca’s IMFINZI® Receives Breakthrough Therapy for Early Gastric and Gastroesophageal Cancers
The US Food and Drug Administration (FDA) has accepted AstraZeneca’s regulatory filing for IMFINZI® (durvalumab) to treat patients with resectable, early-stage gastric and gastroesophageal junction (GEJ) cancers. ...
Revolution Medicine’s Elironrasib Receives FDA Breakthrough Therapy Status for KRAS G12C-Mutated Lung Cancer
Revolution Medicines has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its investigational drug, elironrasib. ...
FDA Grants Breakthrough Therapy Status to Avidity Biosciences' Del-zota for DMD44
Avidity Biosciences has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for its investigational therapy, delpacibart zotadirsen (del-zota). ...
Ensysce Biosciences Receives Positive FDA Feedback on PF614-MPAR for Opioid Safety
Ensysce Biosciences has received encouraging feedback and regulatory guidance from the U.S. Food and Drug Administration (FDA) regarding its novel pain relief product, PF614-MPAR....
